Robinhood CEO Rejects Issuer Veto Over Stock Tokens

Robinhood CEO Vlad Tenev has rejected the idea that publicly traded companies should be able to veto stock-token products linked to their shares, drawing a distinction between corporate shareholder rights and separate market instruments that track a company’s stock. His comments, posted Friday, came amid a dispute involving AMC and add to an ongoing debate over how tokenized exposure to equities should be governed.

Tenev’s position

Tenev said securities issuers should retain control over the rights attached to ownership of their shares. Those rights can include the privileges and claims that accompany holding the underlying security. At the same time, he argued that issuers should not control separate products whose value is designed to follow the price of publicly traded shares.

The distinction is central to the disagreement. A stock token that tracks a listed company’s shares is not necessarily presented as the same legal instrument as the underlying stock. Tenev’s comments indicate that Robinhood views the issuer’s authority as extending to the company’s own securities and shareholder relationship, rather than automatically covering every product that references the company’s market price.

Why the AMC dispute matters

The conflict places the boundary between corporate control and financial-product design at the center of the discussion. AMC is identified in the dispute, but the principle outlined by Tenev could have significance beyond a single company if tokenized products tied to public equities become more common.

Under Tenev’s framework, a company would continue to determine the rights associated with its shares, while a platform or other market participant could potentially offer a separate tracking product without seeking the issuer’s permission. That approach would treat the token as a distinct product rather than as an extension of the company’s shareholder register.

For companies, the issue is whether products linked to their shares should require their consent even when the products do not confer direct shareholder rights. For platforms, the question is whether issuers should be able to restrict products that provide market exposure without transferring the full legal relationship associated with owning the underlying stock.

Market and governance implications

The remarks highlight two competing concerns. Issuers have an interest in maintaining clarity around who holds their securities and which investors receive formal shareholder rights. They may also want to distinguish company-authorized instruments from products created by outside platforms.

Platforms offering stock tokens, by contrast, may argue that a tracking product can be structured independently from the underlying equity. In that view, requiring an issuer veto could allow individual companies to determine whether third parties can create products connected to prices formed in public markets.

The disagreement therefore concerns more than branding or distribution. It raises questions about how the market should classify tokenized exposure, who has authority over the products, and whether a reference to a public company’s shares creates rights for the issuer over a separate instrument. Tenev’s post presents Robinhood’s position clearly: shareholder rights belong under the issuer’s control, while products that merely track a listed share should be treated separately.

What remains unresolved

The available announcement does not settle the legal or commercial status of the products at issue, nor does it establish whether AMC has accepted Robinhood’s interpretation. It also does not indicate how the dispute will be resolved or whether the parties will change their positions.

For now, Tenev’s comments frame the AMC dispute as a test of the limits of issuer authority in tokenized markets. The outcome could influence how companies, trading platforms and investors understand the relationship between traditional shares and digital products that mirror their performance.